Jaguar Health (JAGX) Free Cash Flow Growth (1y) (2015 - 2026)
Jaguar Health (JAGX) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 1,092.51% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 66.37% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 3.98% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 137.65% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 221.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.23% |
| Dec 31, 2025 | 43.27% |
| Sep 30, 2025 | 27.15% |
| Jun 30, 2025 | 30.56% |
| Mar 31, 2025 | -15.87% |
| Dec 31, 2024 | -0.85% |
| Sep 30, 2024 | 2.03% |
| Jun 30, 2024 | 1.47% |
| Mar 31, 2024 | 36.65% |
| Dec 31, 2023 | -45.90% |
| Sep 30, 2023 | 22.27% |
| Jun 30, 2023 | 22.19% |
| Mar 31, 2023 | -29.39% |
| Dec 31, 2022 | 43.06% |
| Sep 30, 2022 | 7.34% |
| Jun 30, 2022 | -17.68% |
| Mar 31, 2022 | -15.10% |
| Dec 31, 2021 | -120.78% |
| Sep 30, 2021 | -223.12% |
| Jun 30, 2021 | -147.08% |